Damian Mikulski

19PUBLICATIONS
90CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsNephrology and urologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 24, 2026
Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

|Feb 27, 2026
Evaluation of mTOR, NFκB, and BCL-2 Inhibitor Activity In Vitro on Diffuse Large B-Cell Lymphoma Cells.

Agata Majchrzak, Sylwia Mańka, Barbara Cebula-Obrzut

|Mar 28, 2025
Primary Renal Lymphoma: Report of 32 Cases-A Retrospective Multicenter PLRG Analysis.

Magdalena Witkowska, Joanna Romejko-Jarosińska, Agnieszka Giza

|Nov 09, 2024
Predictors and Profile of Severe Infectious Complications in Multiple Myeloma Patients Treated with Daratumumab-Based Regimens: A Machine Learning Model for Pneumonia Risk.

Damian Mikulski, Marcin Kamil Kędzior, Grzegorz Mirocha

|Aug 04, 2024
High Serum miR-361-3p Predicts Early Postdischarge Infections after Autologous Stem Cell Transplantation.

Damian Mikulski, Kacper Kościelny, Izabela Dróżdż

Pageof 4

Frequent Collaborators

10 joint publications

Tadeusz Robak

6 joint publications

Kacper Kościelny

5 joint publications

Izabela Drozdz

4 joint publications

Ewelina Perdas